BROAD ARROW PRESENTS RARE OPPORTUNITY TO ACQUIRE FERRARI MONZA SP2 AT CONCORSO D’ELEGANZA VILLA D’ESTE AUCTION2020 FERRARI MONZA SP2 ONE OF ONLY 499 ICONA SERIES SP1 AND SP2 PRODUCED | STRIKING TAILOR MADE LIVERY IN TWO-TONE ROSSO CALIFORNIA WITH A GRIGIO COBURN NOSE SECTION AND ARGENTO NÜRBURGRING ACCENTS | EXTREMELY LOW MILEAGE EXAMPLE SHOWING ONLY 417 KILOMETRES | 6.5-LITRE NATURALLY ASPIRATED V12 PRODUCING 798 HP AND 719 NM OF TORQUE
Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programsMILAN, March 27, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), evolving into Saentra Forge1, a strategic industrial consolidator focused on biotech, defense, aerospace, and Italian national-security-related technologies, today announced that it has entered into a binding offer with Sòphia High Tech S.r.l., (Sòphia HT) an Italian company manufacturing critical parts for Europe's space and defense programs, under which Genenta will fund Sòphia through two reserved capital increases, with the goal of reaching a controlling stake upon the achievement of defined performance milestones. The transaction with Sòphia High Tech would be completed in two phases and remains subject to confirmatory due diligence, required approvals, and definitive transaction documentation.
Huize Holding Limited Reports Unaudited Financial Results for the Second Half and Full Year 2025SHENZHEN, China, March 27, 2026 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (
NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers, and distribution partners digitally through data-driven and AI-powered solutions in Asia, today announced its unaudited financial results for the second half and full year ended December 31, 2025.
New Single-Channel Portable Water-based Condensation Particle Counter Expands OmniCount™ FamilyShoreview, MN, March 27, 2026 (GLOBE NEWSWIRE) -- TSI Incorporated announces the launch of the OmniCount™ Portable Water-based Condensation Particle Counter (PWCPC) Model 3001, expanding its OmniCount™ portfolio with a compact, single-channel solution for accurate ultrafine particle (UFP) measurements in real-world environments.
Global study shows energy industry ramping up investment in autonomous operations by 2030 as AI reshapes performanceHOUSTON, March 27, 2026 (GLOBE NEWSWIRE) -- Schneider Electric, a global energy technology leader, today unveils new research highlighting a powerful combination of pressures pushing autonomous operations to the top of the agenda for the energies and chemicals sector.
Mellow Reaches $100M in 9 Months, Defining the $300B Sleep EconomyLOS ANGELES, CA, March 27, 2026 (GLOBE NEWSWIRE) -- In a category historically defined by fragmented products and incremental innovation, Mellow has fundamentally rewritten the rules of the industry. Launched in 2025, the brand has surpassed $110M sales in just nine months. The milestone signals the arrival of a new era in consumer wellness: the Sleep Economy.
DDPAI Expands North American Availability with Amazon Canada LaunchTORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- Following the showcase at CES, DDPAI is taking a significant step in expanding into the North American market with its launch on Amazon Canada. To give an introduction, we are a dashcam brand committed to enriching the mobility experience with clarity, stability, and smart protection. You may not have heard of us before, but our products are created to provide practical solutions for daily driving and vehicle safety, all at an accessible price.
Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and olderLeiden, the Netherlands, March 27, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending marketing authorization for Joenja® (leniolisib) for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary immunodeficiency, in adult and pediatric patients 12 years of age and older.
Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 MillionWALTHAM, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced the pricing of its underwritten public offering of $200.0 million aggregate principal amount of its 2.50% convertible senior notes due 2032 (the “Convertible Notes” and such offering, the “Convertible Notes Offering”) and its underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $20.00 per share (such offering, the “Equity Offering”).
New Data Reveals the Interview Questions That Cause the Most Candidate Anxiety - And How AI Is Changing ThatNEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- After reviewing patterns across thousands of candidate sessions, LockedIn AI found that interview anxiety isn't random — it spikes around the same handful of questions, and it disproportionately punishes the candidates who prepared the most.
Why the Class of 2025 Refuses to Interview Without AI After Watching a Generation Get Laid OffNEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- LockedIn AI has seen a surge of early-career candidates turning to real-time interview assistance — not as a shortcut, but as a survival strategy in a job market that has left them with almost no margin for error.
PSIX SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Power Solutions International Inc. Investors - Contact Kirby McInerney LLP by May 19, 2026NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP has filed a class action lawsuit, Dishion v. Power Solutions International Inc. et al., No. 26 Civ. 3149, in the United States District Court for the Northern District of Illinois on behalf of investors who acquired Power Solutions International Inc. (“Power Solutions” or the “Company”) (
NASDAQ:PSIX) securities. If you purchased or otherwise acquired securities, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
GO SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Grocery Outlet Holdings Corp. Investors - Contact Kirby McInerney LLP by May 15, 2026NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Grocery Outlet Holdings Corp. (“Grocery Outlet” or the “Company”) (
NASDAQ: GO) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
STMicroelectronics Reports on Resolutions to be Proposed at the 2026 Annual General Meeting of ShareholdersSTMicroelectronics Reports on Resolutions to be Proposed at the 2026 Annual General Meeting of Shareholders
Datacentrex Announces Pricing of $20.17 Million Confidentially Marketed Public Offering at $2.00 per ShareSALT LAKE CITY, March 26, 2026 (GLOBE NEWSWIRE) -- Datacentrex, Inc. (Nasdaq: DTCX) (“Datacentrex” or the “Company”), a digital infrastructure and capital deployment company that owns and operates Scrypt compute assets and evaluates strategic transactions across asset-backed operating businesses, today announced the pricing of its confidentially marketed public offering (the "Offering") of common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock, at a public offering price of $2.00 per share (inclusive of the pre-funded warrant exercise price).
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Hercules Capital, Inc. and Encourages Investors with Large Losses to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hercules Capital (HTGC) To Contact Him Directly To Discuss Their Options
STELLANTIS INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Stellantis N.V. on Behalf of Stellantis Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Stellantis (STLA) To Contact Him Directly To Discuss Their Options
QDRO Acquisition Corp. Announces Pricing of $200 Million Initial Public OfferingNew York, NY, March 26, 2026 (GLOBE NEWSWIRE) -- QDRO Acquisition Corp. (the “Company”), a blank check company whose business purpose is to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced today that it has priced its initial public offering of 20,000,000 units at $10.00 per unit. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. The units will be listed on the Nasdaq Global Market (“Nasdaq”) and will begin trading tomorrow, March 27, 2026, under the ticker symbol “QADRU". Each whole warrant is exercisable to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the Nasdaq under the symbols “QADR” and “QADRW”, respectively.
Instagram’s Algorithm Feeds Antisemitic Content to Millions, New CAM Research FindsWASHINGTON, March 26, 2026 (GLOBE NEWSWIRE) -- The Antisemitism Research Center (ARC) by CAM has released alarming new findings showing that Instagram is actively pushing out antisemitic content to users through its own recommendation engine.
YPF SA reportsBUENOS AIRES, Argentina, March 26, 2026 (GLOBE NEWSWIRE) -- YPF SA announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the US Securities and Exchange Commission, including audited financial statements.
Agicap Selects Chargebee to Power Its Next Phase of Global GrowthAs it expands internationally and moves upmarket, Agicap standardizes billing across entities, currencies, and customer segments with Chargebee.
Rumble Announces Chief Financial Officer Transition~ Mike Masci Named CFO; Brandon Alexandroff to Continue with Company as Strategic Advisor to CEO ~
LeonaBio Reports Full Year 2025 Financial Results and Provides Business UpdateAcquired License to Phase 3 Lasofoxifene Development Program of Novel Selective Estrogen Receptor Modulator (SERM), a Potential Multi-Billion Dollar Opportunity as Treatment Option for Breast Cancer Patients with ESR1-Mutations
Fortuna files Form 40-F, Annual ReportVANCOUVER, British Columbia, March 26, 2026 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) announces that it has filed its annual report on Form 40-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (“SEC”).
Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025Q4 2025 revenues were $13.4 million, up 29.7% from Q4 2024. This was an all-time quarterly record for the Company.
Onco360® Has Been Selected as the National Pharmacy Partner for LIFYORLI™ (relacorilant)LOUISVILLE, Ky., March 26, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Corcept Therapeutics for LIFYORLI™ (relacorilant), which is indicated in combination with nab-paclitaxel for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior systemic treatment regimens, at least one of which included bevacizumab.1
Proposed Merger Approved by Shareholders of CVB Financial Corp. and Shareholders of Heritage Commerce Corp.ONTARIO, Calif. and SAN JOSE, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- CVB Financial Corp. (
NASDAQ: CVBF), the holding company for Citizens Business Bank, and Heritage Commerce Corp (
NASDAQ: HTBK), the holding company for Heritage Bank of Commerce, today jointly announced that each company’s respective shareholders have voted to approve the proposed merger of Heritage Commerce Corp with and into CVB Financial Corp.
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic ProtoporphyriaWATERTOWN, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (
NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that the last participant has been randomized and dosed in the pivotal Phase 3 APOLLO trial of bitopertin in EPP. Originally planned as an N=150 study, the study was expanded to 183 participants due to patient and physician demand.
EKU No. 1 for Military FriendlyⓇ SchoolsRichmond, Kentucky, March 26, 2026 (GLOBE NEWSWIRE) -- Eastern Kentucky University (EKU) has been named the No. 1 large public university in the nation in the 2026-27 Military FriendlyⓇ Schools rankings.
Rapid7 Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)BOSTON, March 26, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (
NASDAQ: RPD), a global leader in AI-powered managed cybersecurity operations, announced that the company granted inducement awards, effective as of March 26, 2026, to employees and contractors of Kenzo Security, Inc. (“Kenzo”) in connection with Rapid7’s acquisition of Kenzo on March 26, 2026, as a material inducement for the Kenzo employees and contractors to commence employment with Rapid7 and its subsidiaries following Rapid7’s acquisition of Kenzo.
Sticker Mule begins accepting crypto paymentsAMSTERDAM, N.Y., March 26, 2026 (GLOBE NEWSWIRE) -- Sticker Mule, the largest privately-owned Internet printing company, now accepts crypto payments at checkout.
Middlesex Water Company Appoints Tatyana Kaplan as Vice President and Chief Accounting OfficerISELIN, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Middlesex Water Company (
NASDAQ: MSEX) has announced today that Mrs. Tatyana Kaplan joined the company as Vice President and Chief Accounting Officer, effective March 26, 2026.
Acuity Inc. Declares Quarterly DividendAtlanta, March 26, 2026 (GLOBE NEWSWIRE) -- Acuity Inc. (
NYSE: AYI) will pay a quarterly dividend of 20 cents per share. The dividend is payable on May 1, 2026, to shareholders of record on April 17, 2026.
UPDATE: Out of Home Advertising Revenue Reaches Record $9.46 Billion19 Consecutive Quarters of Growth Underscore OOH’s Expanding Role in the Modern Media Mix as Apple, Morgan & Morgan, and Vivint top the list of OOH advertisers
ROC Access Face1 Wins “Best in Biometrics” at ISC West 2026 Security Industry Association New Products and Solutions AwardsIndustry recognition validates ROC’s innovation in intelligent biometric access control hardware embedded with real-time threat detection capabilities
As Soccer Takes Center Stage, Boys & Girls Clubs of America Expands Youth Soccer Access NationwideThrough powerful partnerships, the national youth-serving organization is removing barriers to youth soccer and inspiring the next generation through the “beautiful game”
Rapid7 Acquires Kenzo Security to Accelerate Preemptive, AI-Powered Security OperationsAcquisition expands Rapid7’s Command Platform to deliver scalable, machine-speed detection and response that disrupts attackers
Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in AcromegalyApplication supported by comprehensive clinical program, including two positive Phase 3 trials evaluating once-daily oral paltusotine in acromegaly
Datacentrex Announces Proposed Public OfferingSALT LAKE CITY, March 26, 2026 (GLOBE NEWSWIRE) -- Datacentrex, Inc. (Nasdaq: DTCX) (“Datacentrex” or the “Company”), a digital infrastructure and capital deployment company that owns and operates Scrypt compute assets and evaluates strategic transactions across asset-backed operating businesses, today announced that it has commenced a public offering of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. The Company intends to use the net proceeds from this proposed offering (the “Offering”) for working capital and general corporate purposes. The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.
Iridex Reports Fourth Quarter and Full Year 2025 Financial ResultsStrong Q4 and Full Year 2025 Revenue Performance Underpinned by Continued Operational Efficiencies
Galapagos Announces Nomination of Gino Santini to its Board of DirectorsSubject to his election by shareholders, the Board intends to appoint Mr. Santini as Chair, succeeding Jérôme Contamine
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial ResultsAdvancing first-to-market autoimmune CAR T opportunity in stiff person syndrome (SPS) with key launch preparation activities underway; BLA submission anticipated in 1H 2026
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $403 MillionSAN FRANCISCO and BOSTON, March 26, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with the potential for best-in-class profiles in the largest inflammatory and immunology (I&I) markets, today announced the closing of its previously announced underwritten public offering of 5,750,000 shares of its common stock, including the full exercise of the underwriters’ option to purchase up to 750,000 additional shares, at a public offering price per share of $70.00. The aggregate gross proceeds to Apogee from the offering were approximately $403 million before deducting underwriting discounts and commissions and other offering expenses payable by Apogee.
Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent ActivityWILMINGTON, Del., March 26, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, Pulmonary Arterial Hypertension (“PAH”), today reported financial results for the year ended December 31, 2025 and highlighted recent developments.
Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ MeetingsMechelen, Belgium; March 26, 2026, 21:01 CET; regulated information — Galapagos NV (Euronext & NASDAQ: GLPG) today published its annual report for the financial year 2025 and announced that its Annual Shareholders’ Meeting (AGM) and an Extraordinary Shareholders' Meeting (EGM) will be held sequentially on Tuesday, April 28, 2026 at 14:00 CET and 15:00 CET at Schaliënhoevedreef 20T, 2800 Mechelen, Belgium.
Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common StockWALTHAM, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced that it has commenced underwritten public offerings of its convertible senior notes due 2032 (the “Convertible Notes” and such offering, the “Convertible Notes Offering”) and shares of its common stock (the “Equity Offering”).
Introducing PDIQ: The AI Foundation Purpose‑Built for the Convenience and Fuel EcosystemEmbedded across PDI solutions, PDIQ brings AI into industry workflows to help teams make quicker decisions, reduce manual processes, and act with confidence
“Fined $750,000 for discriminatory speech”- BC’s Barry Neufeld explains his case with News Forum analyst Rav Arora in an exclusive interviewST. CATHARINES, Ontario, March 26, 2026 (GLOBE NEWSWIRE) -- Rav Arora sits down with Barry Neufeld to discuss the $750,000 penalty by the BC Human Rights Tribunal. Watch the Exclusive Interview with Host Rav Arora, on The News Forum Saturday March 28 at 8PM ET/MT.
KOIL Energy Solutions Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference CallHOUSTON, March 26, 2026 (GLOBE NEWSWIRE) -- Koil Energy Solutions, Inc. (OTCQB: KLNG), a specialist in deepwater energy production and distribution equipment and services, announced today that it will report its fourth quarter and full year 2025 results on Tuesday, March 31, 2026, before the market opens.
Alamos Gold Provides Notice of Completion of Annual FilingsTORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today announced that it has filed its annual information form and 2025 annual report on Form 40-F, including its audited financial statements for the year ended December 31, 2025, with the SEC on EDGAR as well as the Canadian securities authorities on SEDAR+. These documents are also available at www.alamosgold.com and a hard copy will be provided to shareholders free-of-charge upon request.
The Innocent Lives Foundation Has a New CEOThe Innocent Lives Foundation (ILF), a nonprofit organization founded in 2017 by cybersecurity and human behavior expert Chris Hadnagy, announces the appointment of Kristy Nordmann as its new Chief Executive Officer.
NAEA Highlights “Find a Tax Expert” Directory as Taxpayers Navigate AI-Driven Filing SeasonNational association urges taxpayers to pair emerging AI tools with trusted professional expertise for accuracy, compliance, and data security
Wake Radiology Chief Operating Officer Parul Galloway Receives 2026 Women in Business Award by the Triangle Business JournalRecognition Celebrates Ms. Galloway’s Leadership, Mentorship and Painstaking Efforts in Expanding Access to Exceptional Patient Care
Transaction in Own SharesTransaction in Own Shares
B&H Celebrates World Backup Day with Special Savings, Education and Resources on Storage SolutionsEmpowering creators and consumers to protect their digital assets with expert guidance, plus special deals and savings on essential and reliable backup tools
